Court Divide Could Spur More Hatch-Waxman Venue Fights
By Matthew Bultman (January 5, 2018, 3:07 PM EST) -- A question that affects where drugmakers can sue their generic competitors has split district courts following the U.S. Supreme Court's landmark TC Heartland decision in May, likely giving rise to more fights over venue in cases involving abbreviated new drug applications under the Hatch-Waxman Act.
The TC Heartland v. Kraft Food Brands Group decision limited the filing of patent lawsuits to either where a defendant is incorporated or has committed an act of infringement and has a regular and established place of business. The split among district courts revolves around what is considered an "act of infringement" to support venue in...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!